(BIOG-B) BioGaia (publ) - Performance -11.8% in 12m
Compare BIOG-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
12.58%
#29 in Group
Rel. Strength
32.61%
#5379 in Universe
Total Return 12m
-11.76%
#62 in Group
Total Return 5y
15.74%
#38 in Group
P/E 28.9
68th Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 4.01%
92th Percentile in Group
12m Total Return: BIOG-B (-11.8%) vs XBI (-1.8%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
| HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
| AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
| LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
| KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
| ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: BIOG-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIOG-B
| Total Return (including Dividends) | BIOG-B | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.90% | 2.28% | -0.87% |
| 3 Months | -15.57% | -10.48% | -7.58% |
| 12 Months | -11.76% | -1.83% | 11.88% |
| 5 Years | 15.74% | -12.72% | 110.33% |
| Trend Score (consistency of price movement) | BIOG-B | XBI | S&P 500 |
| 1 Month | -34.2% | 56.6% | 23% |
| 3 Months | -91.7% | -89.3% | -88.5% |
| 12 Months | -46.9% | -42.4% | 55.1% |
| 5 Years | 55.3% | -53.6% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #149 | -8.98% | -6.09% |
| 3 Month | #89 | -5.68% | -8.64% |
| 12 Month | #63 | -10.1% | -21.1% |
| 5 Years | #37 | 32.6% | -45.0% |
FAQs
Does BIOG-B BioGaia (publ) outperforms the market?
No,
over the last 12 months BIOG-B made -11.76%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months BIOG-B made -15.57%, while XBI made -10.48%.
Over the last 3 months BIOG-B made -15.57%, while XBI made -10.48%.
Performance Comparison BIOG-B vs Indeces and Sectors
BIOG-B vs. Indices BIOG-B is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.98% | -6.03% | -0.98% | -23.6% |
| US NASDAQ 100 | QQQ | -4.01% | -8.30% | -1.41% | -24.4% |
| US Dow Jones Industrial 30 | DIA | -2.04% | -3.72% | -0.89% | -21.0% |
| German DAX 40 | DAX | -1.75% | -8.22% | -20.5% | -36.4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.98% | -4.08% | 2.01% | -17.7% |
| Hongkong Hang Seng | HSI | -1.99% | -6.96% | -2.90% | -25.7% |
| India NIFTY 50 | INDA | -0.14% | -11.0% | -1.27% | -14.8% |
| Brasil Bovespa | EWZ | -2.18% | -11.5% | -4.68% | -5.94% |
BIOG-B vs. Sectors BIOG-B is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.23% | -5.85% | -7.11% | -35.7% |
| Consumer Discretionary | XLY | -3.06% | -6.80% | -3.49% | -25.1% |
| Consumer Staples | XLP | 0.52% | -7.10% | -6.29% | -23.0% |
| Energy | XLE | 1.50% | 6.96% | 4.81% | -0.67% |
| Financial | XLF | -1.59% | -4.79% | -8.58% | -34.5% |
| Health Care | XLV | -2.90% | -3.11% | 0.71% | -13.5% |
| Industrial | XLI | -3.40% | -7.01% | -1.69% | -21.4% |
| Materials | XLB | -2.37% | -4.47% | 6.43% | -8.24% |
| Real Estate | XLRE | -1.46% | -5.59% | -0.09% | -29.9% |
| Technology | XLK | -5.43% | -8.59% | 2.36% | -19.5% |
| Utilities | XLU | -0.14% | -6.96% | -3.10% | -33.6% |
| Aerospace & Defense | XAR | -3.93% | -13.3% | -14.5% | -38.3% |
| Biotech | XBI | -4.28% | -9.18% | 11.7% | -9.93% |
| Homebuilder | XHB | -2.29% | -4.63% | 13.8% | -4.73% |
| Retail | XRT | -1.41% | -6.34% | 4.59% | -9.02% |